Login
REGISTER
What Users Get:
Complete Your Profile
Change Password
Request a Password Reset
Home > Tenders > Tigecycline 50 mg powder inj, Qty: 180 Vial, (BOQ Item #9)
Tender for Tigecycline 50 mg powder inj, Qty: 180 Vial, (BOQ Item #9) from Punjab. The reference number of the tender is: 123036520 and the same is closing on 4th Aug 2025. Users can register on the site to get similar tenders.
Procurement Summary
Country : India
State : Punjab
Summary : Tigecycline 50 mg powder inj, Qty: 180 Vial, (BOQ Item #9)
Deadline : 04 Aug 2025
Purchaser's Detail
Other Information
Notice Type : Tender
RefID : 123036520
Notice Ref. No. : GEM/2025/B/6474889
Tender Value : Refer Document
Tender EMD : Refer Document
Tender Document Cost : Refer Document
Competition : NCB
Financier : Self Financed
Purchaser Ownership : Public
Tender's Details
BOQ Item Description: As Per Specifications (Pdf Attached)
BOQ Title: Tab Mycophenolate Sodium 180 mg, Tenofovir Disoproxil Fumarate + Lamivudine + Efavirenz Tablets (V2)
Item Title: Tigecycline 50 mg powder inj
Item Quantity: 180
Unit of Measure: Vial
Delivery Period (In number of days): 21
Start Date: 20-07-2025 5:40 PM
End Date: 04-08-2025 6:00 PM
BOQ Title: Tab Mycophenolate Sodium 180 mg
GeMARPTS Searched: Tenofovir Disoproxil Fumarate + Lamivudine + Efavirenz Tablets (V2)
Get Local Agent Support for this Tenders.
ContactUs1 State
Rs. 2500 + GST
Unlimited Website Access
Unlimited Tenders Download
Unlimited Keyword Search
Access to Archive Tenders
Number of Accounts-1
Dedicated Key Account Manager
24*7 Customer Support
Validity-12 Months
5 States
Rs. 5000 + GST
Unlimited Website Access
Unlimited Tenders Download
Unlimited Keyword Search
Access to Archive Tenders
Number of Accounts-2
Dedicated Key Account Manager
24*7 Customer Support
Validity-12 Months
All India
Rs. 9000 + GST
Unlimited Website Access
Unlimited Tenders Download
Unlimited Keyword Search
Access to Archive Tenders
Number of Accounts-3
Dedicated Key Account Manager
24*7 Customer Support
Validity-12 Months
Browse Tenders from below Sections